Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
DBL Zoledronic Acid IV Infusion
Zoledronic acid monohydrate 4.3mg equivalent to zoledronic acid 4mg
Solution for infusion
Pfizer New Zealand Limited
Laboratorios Grifols S.A, Barcelona, Spain
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Imatinib-Teva
Imatinib mesilate 119.469mg equivalent to imatinib 100mg
Film coated tablet
Teva Pharma (New Zealand) Limited
PLIVA Croatia Limited, Zagreb, Croatia
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Imatinib-Teva
Imatinib mesilate 477.877mg equivalent to imatinib 400mg
Film coated tablet
Teva Pharma (New Zealand) Limited
PLIVA Croatia Limited, Zagreb, Croatia
|
Dated this 3rd day of April 2018.
ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz